Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Where Will AbbVie Be in 5 Years?
09:30am, Monday, 01'st May 2023
AbbVie is facing Humira's loss of exclusivity, but it is working on fixing that problem. The company should earn approval for new products, thereby improving its lineup.
AbbVie Stock Plunged: Should You Buy the Dip?
05:51am, Monday, 01'st May 2023
AbbVie's shares crashed last week after the company reported its Q1 results. The drugmaker's revenue fell due to plummeting sales of Humira and challenges for other products.
7 High-Yield Dividend Stocks to Buy and Hold Forever
02:48pm, Sunday, 30'th Apr 2023
The major indices have been trading in a broad range for over a year. This is frustrating for bulls and bears alike.
AbbVie's Blockbuster Is Falling Fast. Time to Sell?
05:41am, Sunday, 30'th Apr 2023
AbbVie stock recently dropped by about 8% in a single day after the company released a disappointing first-quarter earnings report. Humira's global sales peaked above $21 billion, but the drug lost pa
3 Unstoppable Stocks to Buy Right Now
06:14am, Saturday, 29'th Apr 2023
AbbVie has several blockbusters to drive growth despite facing sales declines for Humira. Pfizer has much better long-term prospects than might meet the eye.
Why AbbVie Stock Is Crashing Today
02:25pm, Thursday, 27'th Apr 2023
AbbVie reported 2023 first-quarter earnings today. Hefty declines in immunology, oncology, and medical aesthetics sales sparked a sell-off in the drugmaker's stock.
1 Dividend Stock to Buy Hand Over Fist in May and 1 to Avoid
08:30am, Thursday, 27'th Apr 2023
Companies that pay sustainable dividends do so with the help of steady cash flows. AbbVie's dividend is relatively sustainable, and it's also likely to keep rising.
AbbVie stock falls toward a 6-week low after adjusted profit fell short of expectations, but the full-year outlook was raised
08:15am, Thursday, 27'th Apr 2023
Shares of AbbVie Inc. ABBV dove 6.2% toward a six-week low in premarket trading Thursday, after the biopharmaceutical company missed first-quarter profit expectations but lifted its full-year outlook.
Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More
10:40am, Wednesday, 26'th Apr 2023
Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.
Strong Small-Cap Insider Buys: Q1 2023
12:15am, Wednesday, 26'th Apr 2023
Strong Small-Cap Insider Buys: Q1 2023.
3 Winning Stocks to Buy No Matter What the Market Is Doing
06:00am, Tuesday, 25'th Apr 2023
AbbVie and Intuitive Surgical benefit from their leadership in their markets -- and ongoing demand in healthcare. Home Depot has added $40 billion in sales growth in recent years.
The Best Stocks to Invest $20,000 in Right Now
02:00pm, Sunday, 23'rd Apr 2023
Investing across a few different companies could bring a lot of positive elements to your portfolio -- from dividends to growth potential. Healthcare is a great place to look for safe stocks and stock
3 Top Dividend Kings to Buy for the Long Haul
07:20am, Saturday, 22'nd Apr 2023
Johnson & Johnson just raised its quarterly dividend for the 61st straight year. AbbVie is counting on Skyrizi and Rinvoq and its deep pipeline to help replace lost revenue from Humira.
4-Factor Dividend Growth Portfolio - Sour Month
12:35pm, Wednesday, 19'th Apr 2023
The 4-factor dividend growth portfolio was launched on November 1st, 2022, and despite a poor start to April the long term return is still attractive. The portfolio outperformed the S&P 500 Total Retu
How To Allocate $10,000 Among My Top 20 Dividend Stocks Of April 2023
02:00pm, Monday, 17'th Apr 2023
In this article, I will show you how you could allocate $10,000 among my top 20 dividend growth and high dividend yield companies for the month of April. Due to the allocation I have chosen, that I'll
